Symbol
| NFATC2
| contributors: mct/npt/pgu - updated : 25-04-2012
|
HGNC name
| nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
|
HGNC id
| 7776
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
|  
| loss of function
|
not only protects the heart from pathological hypertrophy but also efficiently counteracts myocardial functional deterioration following biomechanical stress | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
cardiovascular | aquired | heart failure | |
targeting either NFATc2 activation or its immediate downstream target genes provide a suitable approach for future drug design to treat forms of pathological cardiac hypertrophy and heart failure | cancer | digestive | pancreas | |
inactivation of oncogenic NFATc2 might be an attractive strategy in treatment of pancreatic cancer |
| | | |